Shenzhen Salubris Pharmaceuticals Co Ltd (SZSE:002294) Share Price

Company Profile

Business description
Shenzhen Salubris Pharmaceuticals Co Ltd is a pharmaceutical company dedicated to the research, development, and sale of medical products for cardiovascular diseases, cephalous antibiotics, and bone resorption inhibitors. Its products mainly focused on the areas of cardio-cerebral vascular disease, diabetes, and complications, anti-tumor, and orthopedics, Its business lines include high-end chemical drugs, biological drugs, and medical devices. Its businesses are located in China, the United States, Germany, France, and Japan, and other countries and regions.
Contact
No. 6009 Shennan Road
37th Floor, Main Building, Chegongmiao Lvjing Plaza
Futian District, Guangdong
Shenzhen518040
CHN
T: +86 75583867888
https://www.salubris.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2025
Employees
3,596

Recommended

With a diverse portfolio of innovative technology and integrated media platforms, here’s what we think of Alphabet’s stock.

Malik Ahmed Khan, CFA | 30 July 2025

Bapcor signalled lower underlying profits for fiscal 2025, while an audit cast doubt on the firm’s past earnings.

Angus Hewitt, CFA | 30 July 2025

Our latest articles about where we see opportunities in the market.

Morningstar | 28 July 2025

Index	Last price	Change	% Change
All Ordinaries	9,015.40	48.70	0.54%
CAC 40	7,903.68	46.32	0.59%
DAX 40	24,255.49	38.12	0.16%
Dow JONES (US)	44,632.99	204.57	-0.46%
FTSE 100	9,119.63	16.69	-0.18%
HKSE	25,176.93	347.52	-1.36%
NASDAQ	21,098.29	80.29	-0.38%
Nikkei 225	40,654.70	19.85	-0.05%
NZX 50 Index	12,855.97	80.44	-0.62%
S&P 500	6,370.86	18.91	-0.30%
S&P/ASX 200	8,756.40	51.80	0.60%
SSE Composite Index	3,615.72	6.01	0.17%